AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2018
Jan 12, 2018
3174_iss_2018-01-12_6de233cf-28e3-43dd-bc62-006a06f9b881.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Armistice Captal LLC (Delaware US LLC)
Instrument
| Instrument | Shares SE0003613090 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 09/01/2018 | |
| Limit for number of shares | 10 % | |
| Limit for number of votes | 10 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,746,000 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 1,746,000 | |
| Percentage | ||
| Directly held shares | 10.01103 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 10.01103 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 10.01103 % | 1,746,000 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 10.01103 % | 1,746,000 |
| Chain of controlling companies Voting rights % Voting rights Company |
||
| 1,746,000 10.01103 | Armistice Capital Master Fund Ltd |
Group total holdings Voting rights 1,746,000 Percentage of voting rights 10.01103
Published
12/01/2018 17:21 Contact
Name Steve Chen Tohuan Phone 2122314932 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13